Profilo
Bernd Hentsch is currently a Director at G2M Cancer Drugs AG since 2001.
He was previously a Chief Development Officer at 4SC AG and TopoTarget UK Ltd. Dr. Hentsch holds a doctorate degree from Julius-Maximilians-Universität Würzburg.
Posizioni attive di Bernd Hentsch
| Società | Posizione | Inizio |
|---|---|---|
G2M Cancer Drugs AG
G2M Cancer Drugs AG Miscellaneous Commercial ServicesCommercial Services Researches new anti-cancer therapeutics and develops selected late-stage products | Direttore/Membro del Consiglio | 01/01/2001 |
Precedenti posizioni note di Bernd Hentsch
| Società | Posizione | Fine |
|---|---|---|
| 4SC AG | Corporate Officer/Principal | - |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade Develops anti-cancer drugs | Corporate Officer/Principal | - |
Formazione di Bernd Hentsch
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
4SC AG
4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
G2M Cancer Drugs AG
G2M Cancer Drugs AG Miscellaneous Commercial ServicesCommercial Services Researches new anti-cancer therapeutics and develops selected late-stage products | Commercial Services |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade Develops anti-cancer drugs | Retail Trade |
Julius-Maximilians-Universität Würzburg
Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















